Drugs / ARTICE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05442710 | Jul 2022 → Mar 2026 overdue | infectious disease with sepsis | Artcline GmbH | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARTICE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05442710 ↗ |
| Route | Other | “Extracorporal treatment with purified granulocyte concentrate” NCT05442710 ↗ |